Stockscreener 앱 받기
1.025
0.97%
-0.01
시장 영업 전:
1.03
0.005
+0.49%
전일 마감가:
$1.035
열려 있는:
$1.07
하루 거래량:
563.22K
Relative Volume:
2.08
시가총액:
$57.89M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-47.16%
1개월 성능:
-54.04%
6개월 성능:
-60.88%
1년 성능:
-80.95%
1일 변동 폭
$1.00
$1.07
1주일 범위
$0.972
$2.02
52주 변동 폭
$0.972
$5.6084
Tuhura Biosciences Inc Stock (HURA) Company Profile
명칭
Tuhura Biosciences Inc
전화
813-875-6600
주소
10500 UNIVERSITY CENTER DR., TAMPA
HURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
1.025 | 58.45M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-03 | 개시 | H.C. Wainwright | Buy |
| 2024-12-19 | 개시 | Rodman & Renshaw | Buy |
| 2024-11-05 | 개시 | Maxim Group | Buy |
Tuhura Biosciences Inc 주식(HURA)의 최신 뉴스
TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone - PR Newswire
TuHURA Biosciences (NASDAQ:HURA) Rating Lowered to Sell at Wall Street Zen - Defense World
TuHURA Biosciences provides corporate update after $15.6M financing By Investing.com - Investing.com South Africa
TuHURA Biosciences (NASDAQ: HURA) outlines 2026 trial milestones after $15.6M raise - Stock Titan
TuHURA Biosciences Announces Securities Purchase Agreement - TipRanks
Big Drops For Top Wealth, TuHURA Biosciences, And AutoZone - Finimize
Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More - ts2.tech
TuHURA Biosciences announces $15.6M registered direct offering - TipRanks
TuHURA Biosciences plunges after $15.6 million direct stock deal - TradingView — Track All Markets
TuHURA Biosciences announces $15.6 million registered direct offering - Investing.com
TuHURA Biosciences announces $15.6 million registered direct offering By Investing.com - Investing.com Nigeria
Sabio Holdings (TSXV: SBIO, OTCQB: SABOF) inks Creator TV pact with MADCOOL Media - Stock Titan
Liminatus Pharma (LIMN) Competitors and Alternatives 2025 - MarketBeat
TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor as A New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors At the 57Th Annual Meeting and Exposition - marketscreener.com
TuHURA Biosciences presents research on potential role of DOR at ASH - TipRanks
TuHURA Biosciences presents data on DOR’s role in cancer immunotherapy By Investing.com - Investing.com South Africa
TuHURA Biosciences presents data on DOR’s role in cancer immunotherapy - Investing.com India
TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors at the 57th ASH Annual Meeting and Exposition - PR Newswire
Tuhura Biosciences amends loan agreement, secures full $3M - MSN
TuHURA Biosciences (HURA) Stock Analysis Report | Financials & Insights - Benzinga
TuHURA Biosciences (NASDAQ:HURA) Rating Increased to Hold at Wall Street Zen - MarketBeat
TuHURA Biosciences Amends Loan Agreement, Secures Full $3M - TipRanks
Can TuHURA Biosciences Inc. (PL3) stock deliver double digit returnsJuly 2025 Technicals & Verified Swing Trading Watchlists - Newser
What drives TuHURA Biosciences Inc stock pricePortfolio Diversification Tips & Superior Capital Growth - earlytimes.in
Will TuHURA Biosciences Inc. (PL3) stock deliver compounding returnsMarket Performance Summary & Fast Moving Stock Watchlists - Newser
Will TuHURA Biosciences Inc. stock reach all time highs in 2025July 2025 Opening Moves & Intraday High Probability Alerts - Newser
Is TuHURA Biosciences Inc. (PL3) stock a buy during volatile markets2025 Analyst Calls & Consistent Profit Trade Alerts - Newser
Can TuHURA Biosciences Inc. (PL3) stock sustain revenue momentumCPI Data & Free Community Supported Trade Ideas - Newser
Why TuHURA Biosciences Inc. (PL3) stock benefits from AI revolutionMarket Performance Summary & Proven Capital Preservation Tips - Newser
Can TuHURA Biosciences Inc. (PL3) stock beat analyst consensusEarnings Overview Summary & Stock Portfolio Risk Management - Newser
Stock Market Recap: Can TuHURA Biosciences Inc. stock weather global recessionEntry Point & Fast Gain Stock Trading Tips - moha.gov.vn
Top investors say TuHURA Biosciences Inc (HURA) ticks everything they need - Setenews
TuHURA Biosciences shelf registration statement becomes effective By Investing.com - Investing.com Australia
TuHURA Biosciences’ Shelf Registration Statement Effective - TipRanks
TuHURA Biosciences shelf registration statement becomes effective - Investing.com
TuHURA Biosciences Announces Effective Shelf Registration Statement - TradingView
TuHURA Biosciences (NASDAQ:HURA) Downgraded to Sell Rating by Wall Street Zen - Defense World
Equities Analysts Offer Predictions for HURA FY2025 Earnings - MarketBeat
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Zacks Small Cap Issues Optimistic Forecast for HURA Earnings - Defense World
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Average Rating of “Buy” from Brokerages - Defense World
How TuHURA Biosciences Inc. stock performs in weak economyJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Is TuHURA Biosciences Inc. stock safe for conservative investorsJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
Can TuHURA Biosciences Inc. (PL3) stock hit consensus price targets2025 Performance Recap & Technical Pattern Based Signals - newser.com
Why TuHURA Biosciences Inc. stock is trending among retail tradersJuly 2025 Outlook & Safe Capital Preservation Plans - newser.com
Is it too late to sell TuHURA Biosciences Inc.2025 Big Picture & Weekly High Return Opportunities - newser.com
Tuhura Biosciences Inc (HURA) 재무 분석
Tuhura Biosciences Inc (HURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):